GA²LEN
 | This article needs additional citations for verification. (March 2011) |
 | This article contains promotional content. (February 2024) |
| Abbreviation | GA²LEN |
|---|---|
Parent organization | European Union |
| Website | www |
GA²LEN, or Global Allergy and Asthma European Network, is a consortium of leading European research centres specialized in allergic diseases, including asthma. Funded by the European Union under the 6th Framework Programme, GA²LEN addresses the growing public health concern of allergic diseases.
Since the launch of the Network, it has grown to include an additional 50 collaborating centres, making GA²LEN one of the largest multidisciplinary networks of researchers in allergy and asthma worldwide. By addressing allergy and asthma in their totality, GA²LEN's stated objective is to benefit the well-being of patients by decreasing the burden of allergic diseases in Europe.
The GA²LEN Network of Excellence (NoE) exists to help integrate research activities in Europe and to establish the structure for a European Research Area of excellence in allergy and asthma.[1] The network aims to accelerate the application of research results into clinical practice, to meet the needs of patients, and to help guide policy development. It also aims to promote training and greater integration between public and private sectors in this medical field.[2]
Personnel
[edit]- Professor Paul van Cauwenberge, University of Ghent - GA²LEN Co-ordinator
- Professor Torsten Zuberbier - GA²LEN President
GA²LEN Publications and Journals
[edit]- Heinzerling, L. M.; Burbach, G. J.; Edenharter, G.; Bachert, C.; Bindslev-Jensen, C.; Bonini, S.; Bousquet, J.; Bousquet-Rouanet, L.; Bousquet, P. J.; Bresciani, M.; Bruno, A.; Burney, P.; Canonica, G. W.; Darsow, U.; Demoly, P.; Durham, S.; Fokkens, W. J.; Giavi, S.; Gjomarkaj, M.; Gramiccioni, C.; Haahtela, T.; Kowalski, M. L.; Magyar, P.; Muraközi, G.; Orosz, M.; Papadopoulos, N. G.; Röhnelt, C.; Stingl, G.; Todo-Bom, A.; von Mutius, E.; Wiesner, A.; Wöhrl, S.; Zuberbier, T. (1 October 2009). "GA2LEN skin test study I: GA²LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe". Allergy. 64 (10): 1498–1506. doi:10.1111/j.1398-9995.2009.02093.x. PMID 19772515. S2CID 26264212.
- Compalati, E.; Passalacqua, G.; Bonini, M.; Canonica, G. W. (1 November 2009). "The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis". Allergy. 64 (11): 1570–1579. doi:10.1111/j.1398-9995.2009.02129.x. PMID 19796205.
References
[edit]- ^ Zuberbier, T.; Aberer, W.; Asero, R.; Abdul Latiff, A. H.; Baker, D.; Ballmer-Weber, B.; Bernstein, J. A.; Bindslev-Jensen, C.; Brzoza, Z.; Buense Bedrikow, R.; Canonica, G. W.; Church, M. K.; Craig, T.; Danilycheva, I. V.; Dressler, C. (July 2018). "The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria". Allergy. 73 (7): 1393–1414. doi:10.1111/all.13397. hdl:10230/35554. ISSN 1398-9995. PMID 29336054.
- ^ "HMC Allergy and Immunology Service bags international accreditation". Gulf Times. 5 October 2018. Retrieved 6 August 2024.